InnovAge Holding Corp.

INNV Healthcare Medical Care Facilities

InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025.

Revenue
+12.1%
EPS
+155.0%
Free cash flow
+18,885.6%
Total debt
−16.7%

Quarter to September 2026, against a year earlier

9.04 0.75 −7.66%
Market cap
$1.2B
P/E
124×
Fwd P/E
20.9×
Dividend yield
—
F-score
6/9
Altman Z
4.58
Beneish M
−3.10
Dividend safety
n/a

InnovAge Holding Corp. (INNV) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, InnovAge Holding Corp. (INNV) trades at a EV/Sales of 1.1×. Over the past ten years it has ranged from 0.4× (April 2025) to 5.4× (March 2021); the current reading is higher than 63% of that period. That is below the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 1.5× 185.02%
FY2025 0.5× (37.53%)
FY2024 0.9× (35.72%)
FY2023 1.3× 91.48%
FY2022 0.7× (82.16%)
FY2021 3.9× (21.42%)
FY2020 5.0× 0.00%
FY2019 5.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.1× (30.32%)
Jun 2026 1.5× 44.16%
Mar 2026 1.1× 52.14%
Dec 2025 0.7× (5.34%)
24 more quarters

Against its own ten years

Low 0.4× High 5.4×
Ten-year median 1.0×
Current reading's percentile 63

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on INNV